Elite in Juvenile Myelomonocytic Leukemia (JMML)
Elite in Juvenile Myelomonocytic Leukemia (JMML)
505 Parnassus Ave # M-647, 
San Francisco, CA 

Overview

Mignon Loh is a Pediatric Hematologist Oncology provider in San Francisco, California. Dr. Loh is rated as an Elite provider by MediFind in the treatment of Juvenile Myelomonocytic Leukemia (JMML). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Juvenile Myelomonocytic Leukemia (JMML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 225 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles in the study of Juvenile Myelomonocytic Leukemia (JMML).

Specialties
Pediatric Hematology Oncology
Licenses
Pediatrics in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

505 Parnassus Ave # M-647, San Francisco, CA 94143

Additional Areas of Focus

Dr. Loh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


16 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
View 13 Less Clinical Trials
Similar Doctors
Distinguished in Juvenile Myelomonocytic Leukemia (JMML)
Pediatric Hematology Oncology
Distinguished in Juvenile Myelomonocytic Leukemia (JMML)
Pediatric Hematology Oncology

Ucsf Pediatrics Associates

1975 4th St, 
San Francisco, CA 
 (3.7 miles away)
Languages Spoken:
English

Christopher Dvorak is a Pediatric Hematologist Oncology provider in San Francisco, California. Dr. Dvorak is rated as an Elite provider by MediFind in the treatment of Juvenile Myelomonocytic Leukemia (JMML). His top areas of expertise are Severe Combined Immunodeficiency (SCID), Juvenile Myelomonocytic Leukemia (JMML), Hepatic Venoocclusive Disease with Immunodeficiency, Bone Marrow Transplant, and Splenectomy.

Distinguished in Juvenile Myelomonocytic Leukemia (JMML)
Pediatrics | Pediatric Hematology Oncology | Hematology
Distinguished in Juvenile Myelomonocytic Leukemia (JMML)
Pediatrics | Pediatric Hematology Oncology | Hematology
400 Parnassus Ave Fl 1, 
San Francisco, CA 
 (0.1 miles away)
Languages Spoken:
English

Benjamin Braun is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in San Francisco, California. Dr. Braun is rated as an Advanced provider by MediFind in the treatment of Juvenile Myelomonocytic Leukemia (JMML). His top areas of expertise are Juvenile Myelomonocytic Leukemia (JMML), Leukemia, Neuroblastoma, and Acute Lymphoblastic Leukemia (ALL).

Advanced in Juvenile Myelomonocytic Leukemia (JMML)
Pediatric Hematology Oncology
Advanced in Juvenile Myelomonocytic Leukemia (JMML)
Pediatric Hematology Oncology
725 Welch Rd, 
Palo Alto, CA 
 (27.4 miles away)
Languages Spoken:
English

Catherine Aftandilian is a Pediatric Hematologist Oncology provider in Palo Alto, California. Dr. Aftandilian is rated as a Distinguished provider by MediFind in the treatment of Juvenile Myelomonocytic Leukemia (JMML). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Infantile Neutropenia, Childhood Acute Myeloid Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Loh's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile